Atlas Trials

Extension Study of the Phase 3 Clinical Study of GZR18 Injection for Weight Loss

Clinical trial NCT07292441 · RECRUITING

Trial details

NCT number
NCT07292441
Sponsor
Gan & Lee Pharmaceuticals.
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Overweight or Obesity
Start date
2026-01-22
Primary completion
2027-09-01
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.